Concepedia

Julie K. Jang

JK

Statistics

Publications

12

Citations

665

H-Index

12

Active since

2008

Affiliations

University of Southern California(Current)

Brigham and Women's Hospital

Monash University

Army Medical University

Xinqiao Hospital

Julie K. Jang is an author at University of Southern California specializing in oncology, tumor immunology, and immunology.

Publications per year

2008–2023

12

Publications

12

MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment <i>In Vitro</i>

Trevor E. Angell, Melissa G. Lechner, Julie K. Jang et al. · Clinical Cancer Research · 2014 · 152 citations · Full text

Life Sciences, Immunology, Oncology +17

BRAF <sup>V600E</sup> in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration

Trevor E. Angell, Melissa G. Lechner, Julie K. Jang et al. · Thyroid · 2014 · 131 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Survival Signals and Targets for Therapy in Breast Implant–Associated ALK <sup>−</sup> Anaplastic Large Cell Lymphoma

Melissa G. Lechner, Carolina Megiel, Connor H. Church et al. · Clinical Cancer Research · 2012 · 115 citations

Medicine, Cell Biology, Oncology +15

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

Samuel Y. Ng, Noriaki Yoshida, Amanda L. Christie et al. · Nature Communications · 2018 · 114 citations · Full text

Medicine, Oncology, Pharmacology +12

VEGF-mediated cross-talk within the neonatal murine thymus

Andrew Cuddihy, Shundi Ge, Judy Zhu et al. · Blood · 2008 · 43 citations · Full text

Life Sciences, Developmental Biology, Immunology +14

1–5 of 12